Clinical trial Recruiting at 1 site Observational Ages 20 to 100

Investigating long-term vascular complications after radiation in head and neck cancer patients

Official title: The Ambidirectional Cohort Study of Neurovascular Complications After Radiation Therapy in Head and Neck Cancer Patients

Run by Chang Gung Memorial Hospital · NCT06111430 · Data updated 2026-11-12

This study looks at how radiation treatment affects blood vessel health over time in people with head and neck cancer, comparing those with nasopharyngeal cancer to others.

More Radiation Treatment trials

Quick facts

Study typeObservational
Ages20 Years to 100 Years
SexAll
Enrollment800 (estimated)
SponsorChang Gung Memorial Hospital
Academic / other
Drugs / interventionsradiation
Locations1 site (Taipei)
StatusRecruiting
StartedApril 11, 2022
Main results expectedApril 10, 2023
Study endsApril 10, 2027
Registry record updatedOctober 22, 2026
Trial IDNCT06111430 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 20 and older who have been diagnosed with head and neck cancer and have received radiation therapy within the last 72 months or more than 120 months ago.

Probably not a fit

Patients under 20 years of age or those unwilling to provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the prevalence of cervical-cranial vascular complications in patients with head and neck cancer who have received radiation therapy. It will compare outcomes between patients with nasopharyngeal cancer and those with other types of head and neck cancers. Participants will be recruited based on their history of radiation treatment and will undergo brain imaging and vascular studies to evaluate complications. The study focuses on both early and long-term effects of radiation therapy on vascular health.

Why it matters

Potential benefit: If successful, this study could improve understanding of long-term vascular risks in head and neck cancer patients, leading to better monitoring and management strategies.

How similar studies have gone: While there is ongoing research into the effects of radiation therapy on vascular health, this specific focus on long-term complications in head and neck cancer patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Population: Prospective cohort

Inclusion Criteria:

1. Age ≥20 years.
2. Head and neck cancer patient .
3. Had ever received radiation therapy (RT) ≦ 72 months before inclusion in the registry.
4. Had ≥ 1 brain images and cervical-cranial vascular studies between the end of RT and d date of enrolment.

Exclusion Criteria:

1. Age \<20 years.
2. Patients not willing to sign the informed consent.

Population: Retrospective validation cohort

Inclusion Criteria:

1. Age ≥20 years.
2. Head and neck cancer patient.
3. Had ever received radiation therapy (RT) \> 120 months before the adoption date of IRB at the participant site.
4. Had ≥ 2 brain images and cervical-cranial vascular studies between the end of RT and 6\~10 years after RT, one within 5 years after RT, the other after 5 years after RT.

Exclusion Criteria:

1.Age \<20 years.

Where it's running

  • Chang Gung Memorial Hospital
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.